TORONTO, May 31, 2021 /PRNewswire/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe, is pleased to announce that the Company´s management will be participating in the following investor:
Jefferies Healthcare ConferenceDate:  June 2nd, 2021Time: 4:00pm ETTo register:  https://wsw.com/webcast/jeff174/khrn/1858869
Benzinga Virtual Cannabis Capital…

Click here to view the original article.